Objective

BRESLIN BIOTECH AG selects and manages private equity investments in the European life science industry, to facilitate success for these companies and to achieve long-term capital appreciation for its investors.

BRESLIN BIOTECH AG offers operating and strategic assistance, expertise in deal structuring, and a range of complementary skills in science and business for entrepreneurs and management of biotech companies. Several financial Partners provide capital resources for the investment portfolio.

BRESLIN BIOTECH AG provides practical guidance in technology, management, markets and finance, leveraging a network of international senior advisors and contacts to biotech-pharma, academia and investors.